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Caspase activation in target cells is a major function of granzyme B (grB) during cytotoxic 
lymphocyte granule-induced apoptosis. grB-mediated cell death can occur in the absence of 
active caspases, and the molecular targets responsible for this additional pathway remain 
poorly defined. Apoptotic plasma membrane blebbing is caspase independent during granule 
exocytosis–mediated cell death, whereas in other instances, this event is a consequence of 
the cleavage by caspases of the Rho effector, Rho-associated coiled coil–containing protein 
kinase (ROCK) I. We show here that grB directly cleaves ROCK II, a ROCK family member 
encoded by a separate gene and closely related to ROCK I, and this causes constitutive 
kinase activity and bleb formation. For the first time, two proteins of the same family are 
found to be specifically cleaved by either a caspase or grB, thus defining two independent 
pathways with similar phenotypic consequences in the cells. During granule-induced cell 
death, ROCK II cleavage by grB would overcome, for this apoptotic feature, the 
consequences of deficient caspase activation that may occur in virus-infected or malignant 
target cells.
 
NK cells and cytotoxic T lymphocytes activate
the latent death machinery in their target cells
by two basic mechanisms (1, 2). One is trig-
gered by cross-linking of cell-surface death
receptors of the TNF receptor superfamily ex-
pressed on the target and consists of a classical
initiator-to-effector caspase cascade, starting with
procaspase-8 autoprocessing. Then, caspase-8
activates effector caspases, such as caspase-3,
either directly or via an amplification loop
involving the release of mitochondrial pro-
apoptotic factors into the cytosol and subse-
quent activation of caspase-9.
The second pathway consists of intracellular
delivery of exogenous proteins into the target
by exocytosis of preformed cytotoxic granules.
The major death effectors contained in the
granules, a family of serine proteases called
granzymes, are internalized in the target and
released from the endosome through the action
of another granule protein, perforin. Granzyme
B (grB), the most potent proapoptotic protease
contained in the granules, displays an aspartase
specificity, which is a property reminiscent of
that of caspases. Once in the cytosol, grB pro-
cesses procaspase-3 between the large and
small subunits at a site also used by caspase-8
(3). In most cases, grB-mediated mitochondrial
alteration is required to fully activate caspase-3
(4), and the triggering of this mitochondrial
loop involves the cleavage of Bid, a proapop-
totic, BH3-only Bcl-2 family member (5). In
this context, granzyme B function is comparable
with that of the apical caspase-8.
More than 200 intracellular substrates of
effector caspases, such as caspase-3, have been
identified, and the cleavage of some of these
substrates is responsible for specific cellular alter-
ations  that characterize the death phenotype
(6). We and others have shown that plasma
membrane blebbing, a ubiquitous morphological
change observed at the onset of apoptosis, results
from caspase-3–induced cleavage and activation
of the serine/threonine kinase Rho-associated
coiled coil–containing protein kinase (ROCK) I,
an effector of the GTPase Rho (7, 8). Deregu-
lated ROCK I increases the phosphorylation
of myosin regulatory light chain (MLC) and
stimulates the actomyosin contraction that is
required for bleb protrusion (9).
 
CORRESPONDENCE
Jacqueline Bréard: 
jacqueline.breard@cep.u-psud.fr
 
Abbreviations used: grB, 
granzyme B; GST, glutathione 
 
S
 
-transferase; MLC, myosin reg-
ulatory light chain; PS, phos-
phatidlyserine; ROCK, Rho-
associated coiled coil–containing 
protein kinase; z-VAD-fmk, 
z-Val-Ala-Asp(Ome)-
fluoromethylketone. 
DIRECT ROCK II CLEAVAGE BY GRANZYME B | Sebbagh et al.
 
466
 
Even though caspase activation is a major pathway of the
apoptosis induced by cytotoxic cells, granule exocytosis can
induce cell death in the absence of active caspases (10, 11).
In addition to cleaving Bid-like caspase-8, grB has been
shown to directly cleave some caspase-3 substrates (12, 13),
and these proteolytic events contribute to the caspase-inde-
pendent component of lymphocyte granule-induced cell
death. Accordingly, Henkart and colleagues have reported
the caspase independence of some cytoplasmic apoptotic fea-
tures induced in target cells by cytotoxic lymphocytes, in-
cluding bleb formation (11). In the present study, we pro-
vide a molecular explanation to this latter observation by
showing that grB directly cleaves and activates ROCK II, a
ROCK family member encoded by a separate gene and
closely related to ROCK I (65% overall homology and 92%
in the kinase domain). This cleavage is shown to be respon-
sible for cytotoxic cell-induced, caspase-independent plasma
membrane blebbing in target cells.
 
RESULTS
ROCK II is cleaved during apoptosis induced by the cytotoxic 
granule pathway in a caspase-independent manner
 
The stimulus for this investigation was the observation that
plasma membrane blebbing was abrogated by the broad
caspase inhibitor z-Val-Ala-Asp(Ome)-fluoromethylketone
(z-VAD-fmk) in various cell types exposed to a series of apop-
Figure 1. ROCK II cleavage during cytotoxic granule-mediated 
apoptosis. (a) K562 cells incubated with LAK cells for 5 h in the presence 
of 20  M z-VAD-fmk, and then stained with 5  g ml 1 Hoechst 33342. 
Photomicrographs of the same field were obtained by phase-contrast mi-
croscopy (left) and by microscopy with ultraviolet irradiation (right). Tar-
get cells are much larger than LAK cells. (arrows) Blebbing target cells; no 
chromatin condensation is detected as caspases are inhibited. (b) Western 
blot analysis of the indicated proteins (MLC, myosin regulatory light chain; 
MLC-P, phosphorylated MLC; Casp-3, caspase-3 active fragments) in lysates 
of K562 cells exposed for the indicated times to LAK cells in the presence 
or absence of 20 M z-VAD-fmk. (c) Western blot analysis of the indicated 
proteins in lysates of K562 cells exposed to LAK cells in the presence or 
absence of 10  M Y-27632 and in the presence or absence of 20  M 
z-IETD-fmk. (b and c) Molecular mass is indicated in kilodaltons. The
anti-MLC antibody was used also as the loading control. Antibodies used 
include H-85 anti–ROCK I and clone 21 anti–ROCK II. Results are represen-
tative of three independent experiments. (d) Quantification of the cleav-
age fragments. Images of the cleavage bands of ROCK I and ROCK II were 
acquired by densitometry scanning (Gel Doc; Bio-Rad Laboratories) and 
analyzed with Quantity One software. Band intensity relative to the base-
line signal (set as 1) is shown in arbitrary units. 
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tosis inducers (7), with the notable exception of apoptosis
induced by cytotoxic granule exocytosis. This is illustrated in
Fig. 1 a where the K562 cell line, which is specifically sensi-
tive to this pathway (14), was used as a target for LAK cells
in the presence of z-VAD-fmk.
Because we had demonstrated previously that caspase-
mediated cleavage of the serine/threonine kinase ROCK I
was responsible for apoptosis-associated membrane blebbing
through increased MLC phosphorylation (7), we examined
the phosphorylation status of MLC in K562 cells exposed to
LAK effector cells. As shown in Fig. 1 b, MLC phosphoryla-
tion increased over the 3-h observation period. This increase
was only moderately affected by the presence of z-VAD-
fmk. In this setting, z-VAD-fmk efficiently prevented ap-
pearance of the ROCK I 130-kD cleavage fragment as well
as that of the p19 and p17 forms of active caspase-3. These
observations indicated that MLC phosphorylation in K562
cells exposed to LAK effector cells was, at least in part, a cas-
pase-independent event. Interestingly, Western blot analysis
of ROCK II detected a peptide whose size (
 
 
 
130 kD) was
similar to the ROCK I cleavage fragment in addition to the
full-length 160-kD protein. This peptide accumulated over
time and this accumulation was not abrogated by z-VAD-
fmk (Fig. 1 b). Quantification of ROCK cleavage fragments
confirmed that z-VAD-fmk reduced ROCK I cleavage to
baseline, but completely spared that of ROCK II (Fig. 1 d,
top). These observations suggested that granule-mediated
apoptosis had the unique property of inducing the cleavage
of both ROCK proteins and that only ROCK I cleavage
was sensitive to caspase inhibitors.
To further document the nature of the caspase-indepen-
dent blebbing of target cells exposed to LAK cells, cytotox-
icity assays were performed in the presence of either a
ROCK inhibitor, Y-27632, or a permeant grB inhibitor,
z-IETD-fmk (15). These two inhibitors prevented both MLC
phosphorylation (Fig. 1 c) and apoptotic blebbing (not de-
picted). Neither the previously described caspase-mediated
cleavage of ROCK I nor the newly identified cleavage of
ROCK II was significantly affected by the presence of
Y-27632. In contrast, inhibition of grB prevented the ap-
pearance of their cleaved form (Fig. 1 c and Fig 1 d, bot-
tom), indicating that grB activity was required for both
events. As expected, grB inhibition also prevented caspase-3
activation (Fig. 1 c).
Together, these observations indicated that death trig-
gered by the cytotoxic granule pathway led to cleavage of
both ROCK proteins under the dependence of grB.
However, only ROCK I cleavage appeared to depend on
z-VAD-fmk–sensitive proteases. Moreover, MLC phos-
phorylation was not abrogated by caspase inhibitors but was
suppressed by either ROCK or grB inhibitors.
 
ROCK II is a granzyme B substrate whereas ROCK I is not
 
The ability of grB to directly cleave ROCK proteins was
tested by using an in vitro assay. To avoid any cleavage by
residual caspase-3 activity, ROCK I and ROCK II were im-
munoprecipitated from caspase-3–deficient MCF-7 cells.
Fig. 2 a shows that ROCK II is efficiently cleaved by grB at
a concentration as low as 1.5 nM, generating a cleavage frag-
ment of similar size to that induced by LAK cells (Fig. 2 a).
In contrast, grB did not cleave ROCK I (Fig. 2 a), even at
the highest tested concentration (e.g., 90 nM; not depicted).
Consistent with our previously published data (7), ROCK I
but not ROCK II was cleaved in lysates of anti-Fas–treated
Jurkat cells used as controls.
To further document these in vitro results, purified grB
was introduced into MCF-7 cells with the Chariot reagent
(16). In these conditions, a ROCK II fragment of a molecu-
lar mass comparable with that observed in vitro was de-
tected, starting 15 min after grB addition (Fig. 2 b). After
30–45 min, the ROCK II fragment did not accumulate any-
more, suggesting that the protein had been cleaved in all
permeabilized cells (Fig. 2 b). In the same type of experi-
ments, ROCK I remained in its native form (not depicted).
Together, these results demonstrate that ROCK II is a direct
substrate for granzyme B in vitro and in vivo, whereas
ROCK I is not.
 
Granzyme B cleaves ROCK II at D
 
1131
 
We previously identified the caspase-3 cleavage site in
ROCK I as DETD
 
1113
 
 (7). A consensus cleavage sequence
for grB, which has been established as I/V/L-G/E-X-D (15),
was identified in ROCK II COOH terminus (IGLD
 
1131
 
 se-
quence) missing in ROCK I (Fig. 3 a). We used site-directed
mutagenesis to substitute the aspartic acid 1131 of ROCK II
by an alanine. WT and mutated D1131A ROCK II tagged
with the AU1 peptide in NH
 
2
 
 terminus were transiently
transfected in MCF-7 cells. Exogenous ROCK II, immuno-
precipitated with an anti-AU1 antibody, was exposed to pu-
rified grB in an in vitro cleavage assay. Mutated D1131A
ROCK II was not cleaved by grB (Fig. 3 b), indicating that
ROCK II cleavage occurred at aspartic acid 1131.
Figure 2. ROCK II in vitro and in vivo cleavage by purified grB. 
(a) ROCK II or ROCK I was immunoprecipitated from MCF-7 cells, and then 
incubated with the indicated concentrations of grB for 60 min at 37 C before 
performing Western blot analysis of ROCK II (left) and ROCK I (right). West-
ern blot analysis of Jurkat cells, either left untreated (Jurkat) or treated with 
an agonistic anti-Fas antibody for 6 h (Jurkat Fas 6h) was used for controls. 
(b) Purified grB was introduced into MCF-7 cells treated with Chariot reagent. 
At the indicated times (minutes) after grB addition, cells were lysed and 
ROCK II was analyzed by Western blotting using clone 21 antibody. 
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Consequences of ROCK II cleavage by granzyme B
 
We have shown previously that ROCK I NH
 
2
 
-terminal
fragment (130 kD) produced by caspase-3 cleavage retained
its ability to bind the GTP active form of Rho (7). We per-
formed an in vitro pull-down assay using glutathione
 
S
 
-transferase
 
 
 
(GST)–Rho loaded with either GDP or GTP
by using extracts of MCF-7 transiently transfected with ei-
ther WT, mutated D1131A ROCK II, or truncated ROCK
II (
 
 
 
ROCK II, truncated at aspartic acid 1131) constructs
tagged with the AU1 peptide. Retained proteins were sepa-
rated by SDS-PAGE, and exogenous ROCK II was revealed
with the anti-AU1 antibody. The three proteins bound pref-
erentially to Rho-GTP, although a weaker signal was ob-
tained with 
 
 
 
ROCK II (Fig. 4 a, top). Equal expression for
the three ROCK II forms was assessed by Western blot anal-
ysis. Reprobing the blot with the anti–ROCK II antibody
directed against the COOH terminus sequence showed that
the level of precipitated endogenous ROCK II was similar
in untransfected and 
 
 
 
ROCK II–transfected cells (Fig. 4 a,
bottom), indicating homogenous pull-down efficiency.
We conclude that the 130-kD, NH
 
2
 
-terminal fragment of
ROCK II generated by grB cleavage still interacts with ac-
tive Rho, albeit with an apparent lower affinity than WT
and D1131A ROCK II proteins.
Caspase-3–mediated removal of the ROCK I COOH ter-
minus inhibitory domain was shown to generate a constitu-
tively active kinase (7, 8). WT and 
 
 
 
ROCK II were transiently
expressed in 293T cells, purified by immunoprecipitation, and
tested in an in vitro kinase assay. 
 
 
 
ROCK II exhibited a higher
kinase activity than WT ROCK II (Fig. 4 b). The extent of ac-
tivation of 
 
 
 
ROCK II compared with WT ROCK II was 2.4-
fold, and thus comparable with ROCK I activation by caspase
cleavage (2.1-fold; not depicted).
To determine whether 
 
 
 
ROCK II was able to induce
plasma membrane blebbing, 293T cells were transiently
cotransfected with either WT or 
 
 
 
ROCK II together with a
plasmid encoding the EGFP protein, in the presence of
z-VAD-fmk. As illustrated in Fig. 5, 
 
 
 
ROCK II, but not WT
ROCK II, triggered the formation of numerous membrane
blebs in transfected cells. Indeed, virtually all the cells trans-
fected with 
 
 
 
ROCK II and EGFP that were EGFP positive
underwent blebbing. Hoechst labeling indicated that the nu-
clei of blebbing cells had a normal appearance; e.g., with no
apoptotic chromatin condensation (not depicted). Likewise,
blebs were not labeled by annexin V, indicating that active
ROCK II does not induce phosphatidylserine externaliza-
tion (not depicted). Membrane blebbing was insensitive to
C3 exoenzyme, a specific inhibitor of Rho, but was totally
abrogated by Y-27632, a specific inhibitor of ROCK (un-
published data). Finally, expression of 
 
 
 
ROCK II, but not
of WT ROCK II, led to a major increase in MLC phos-
phorylation, which was reduced to baseline by Y-27632 but
not by exoenzyme C3 (Fig. 5 b). Efficient ADP ribosylation
and, thus, inhibition of Rho was verified by a mobility shift
Figure 3. Identification of ROCK II cleavage site. (a) Schematic rep-
resentation of the structure of ROCK I and ROCK II. BD, Rho-binding do-
main; PH, pleckstrin homology domain. DETD1113 has been demonstrated 
to be a caspase-3–mediated cleavage site in ROCK I (reference 7). (b) MCF-7 
cells were transiently transfected with either a wild-type (WT) or a mu-
tated (D1131A) ROCK II (the two constructs were tagged in the NH2 termi-
nus with the AU1 peptide). 20 h after transfection, AU-1–tagged proteins 
were immunoprecipitated, exposed to 5 nM grB for 60 min, and analyzed 
by Western blotting using an anti-AU1 antibody. Western blot analysis of 
transiently transfected cell lysates was used as the control.
Figure 4. Properties of cleaved ROCK II. (a) MCF-7 cells were either 
left untransfected (lanes A, B, and J) or transiently transfected with either 
wild-type (WT; lanes C, D, and K) or mutated D1131A (lanes E, F, and L) or 
truncated  1131 (lanes G, H, and M) ROCK II constructs tagged in NH2 
terminus with the AU1 peptide. 22 h after transfection, in vitro pull-down 
assay was performed: lysates were incubated with GDP-bound (A, C, E, 
and G) or GTP-bound (B, D, F, and H) GST-RhoA, and precipitated proteins 
were analyzed by Western blotting with anti-AU1 (top) or anti–ROCK II 
COOH terminus (bottom) antibody. Controls are Western blot analysis of 
GST Rho alone (I) and lysates of cells left untransfected (J) or transfected 
with either WT (K) or D1131A (L) or  1131 (M) AU-1–tagged constructs, 
indicating equal expression of the three transfected constructs in the 
tested cells. The blot was reprobed with the anti–ROCK II COOH terminus 
antibody to verify homogenous pull-down efficiency. (b) In vitro kinase 
assay. 293T cells were either left untransfected (lanes A and E) or tran-
siently transfected with either WT (lanes B and F) or truncated  1131 
(lanes C and G) AU1-tagged ROCK II constructs. 24 h later, cells were 
lysed, and exogenous ROCK II proteins were immunoprecipitated using the 
anti-AU1 antibody (IP AU1) and assayed for kinase activity in vitro with 
myelin basic protein as a substrate (bottom, IVK, in vitro kinase assay). 
Beads alone were used as a control (lane D, Ac beads). The efficiency of 
immunoprecipitation was determined by Western blotting using an anti-
AU1 antibody (top, lanes A–D) with simultaneous analysis of constructs 
expression with an aliquot of cell lysates as controls (lanes E–G). 
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assay (Fig. 5 b). Together, these observations indicated that
 
 
 
ROCK II exhibits a constitutive kinase activity that is suf-
ficient to trigger membrane blebbing, outside of an apop-
totic context, in a Rho- and caspase-independent manner.
 
ROCK II is not cleaved in target cells exposed to granzyme 
B-deficient cytotoxic cells
 
A grB cleavage site similar to that detected in human ROCK
II (IGMD
 
1131
 
 instead of IGLD
 
1131
 
) was identified in rat and
mouse ROCK II. By using in vitro assays, we observed that
grB could cleave mouse ROCK II with a pattern and an ef-
ficacy similar to that observed when studying the human
protein (unpublished data). Thus, GrB-deficient mice were
used to validate our observations in the murine model. The
NK target cells YAC-1 were exposed to IL-2–activated sple-
nocytes from C57Bl/6J (WT) or B6.129S2-
 
Gzmb
 
tm1Ley
 
/J
(
 
gzmb
 
 
 
/
 
 
 
) mice for various times before cell lysis and anal-
ysis by Western blotting. As shown in Fig. 6, both ROCK I
and ROCK II were gradually cleaved in YAC-1 cells cul-
tured with cytotoxic cells derived from WT mice. GrB-defi-
cient splenocytes were still able to induce cleavage of
ROCK I, albeit with a reduced efficiency that is most likely
related to caspase-3 activation through the death receptor
pathway. In contrast, grB-deficient cytotoxic cells were un-
able to induce ROCK II cleavage in YAC-1 targets, thus
showing that ROCK II is a direct grB substrate.
 
DISCUSSION
 
We have demonstrated that ROCK II is cleaved by grB dur-
ing granule-mediated killing of target cells. ROCK II
cleavage by grB removes an inhibitory domain similar to
that deleted in ROCK I by caspase-3 cleavage (7, 8). Conse-
quently, the NH
 
2
 
-terminal fragment of ROCK II contains
the entire kinase domain, is constitutively active, and is suffi-
cient to trigger MLC phosphorylation and plasma membrane
blebbing in a Rho-independent manner. Therefore, the
consequences of ROCK II cleavage by grB are similar to
that of ROCK I cleavage by caspases. This is the first time
that two proteins of a same family, with no functional differ-
ences, are found to be specifically cleaved by either a caspase
or grB, thus defining two specific pathways with similar phe-
notypic consequences in the cells.
Several substrates common to caspases and grB have been
previously identified. Most often, grB and caspase-3 process
these common substrates at different sites, usually within an
 
 
 
15–amino acid span, thus generating distinct cleavage frag-
ments. With few exceptions such as topoisomerase-I or
DNA-PK, inhibition of caspases is necessary to detect grB-
mediated cleavage of the common targets (17). Granule-
mediated apoptosis is associated with grB-mediated cleavage
of both ROCK proteins, and we show here that whereas
ROCK I cleavage is indirect and requires the activation of
caspases, grB cleaves ROCK II directly. This grB-mediated
cleavage of ROCK II is very efficient in that it is readily de-
tectable after 30 min of K562 cells being exposed to killer
cells, in the absence or presence of caspase inhibitors. This ob-
servation is in accordance with our in vitro data showing that
a minimal amount of grB is sufficient to process ROCK II.
Preventing caspase activation during granule-mediated
apoptosis largely inhibits nuclear changes such as chromatin
condensation or DNA oligonucleosomal fragmentation. In
contrast, phosphatidylserine (PS) externalization, mitochon-
drial potential decrease and plasma membrane blebbing in
target cells are not inhibited, suggesting the involvement of
cytoplasmic caspase-independent events (11, 14). PS expo-
Figure 5.  Functional activity of cleaved ROCK II. (a) 293T cells were 
transiently cotransfected with ROCK II and EGFP plasmids in the presence 
of 40 M z-VAD-fmk for 20 h. Images were obtained by phase-contrast 
(right) and fluorescence (left) confocal microscopy of identical fields for 
each population. (top)  ROCK II; (bottom) WT ROCK II. (b) 293T cells were 
either left untransfected or transiently transfected with the indicated 
ROCK II constructs in the absence or presence of 10  M Y-27632 or 50  g/ml 
TAT-C3 for 20 h. Then, lysates were probed with antibodies against phos-
phorylated MLC (MLC-P), MLC (charge control), or AU1 (transfection effi-
ciency control). (bottom) A gel shift assay performed with an anti-RhoA 
antibody that identifies non–ADP-ribosylated (Rho) and ADP-ribosylated 
(Rho*) Rho.
Figure 6. Granzyme B–deficient murine cytotoxic cells fail to induce 
ROCK II cleavage in their target. IL-2 activated splenocytes from WT or 
grB-deficient (gzmb / ) mice were incubated with YAC-1 targets for the 
indicated times at a 2:1 ratio before cells lysis and analysis of ROCK I and 
ROCK II cleavage by Western blotting. Hsc70 was used as a loading control. 
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sure could signal the phagocytosis of target cells despite in-
complete nuclear apoptotic changes. Mitochondrial depolar-
ization is likely caused by grB either as a consequence of Bid
cleavage or via an alternative, Bid-independent pathway
(18). We show here that plasma membrane blebbing is an-
other phenotypic feature of target cell apoptosis that can be
directly mediated by grB through direct cleavage of ROCK
II, thus ensuring the occurrence of this apoptotic change in
cells with either defective or inhibited caspase activation.
Apoptotic bleb formation may have important functional
consequences. Impaired clearance of apoptotic cells by mac-
rophages is known to contribute to the development of au-
toimmune and inflammatory diseases (19–22). Apoptotic
membrane blebs express externalized PS and are a preferred
site for complement C1q and C-reactive protein binding,
events which are implicated in the noninflammatory clear-
ance of dying cells (21, 23–25). Interestingly, most of the
substrates cleaved by both caspase-3 and by grB are nuclear
autoantigens that redistribute and cluster in blebs and/or ap-
optotic bodies (17, 26–28). Bleb recognition and engulfment
by phagocytes permits the efficient removal of packaged cas-
pase and/or grB substrates, and may participate in the main-
tenance of tolerance to self proteins.
The autoantigenic status of grB substrates, as opposed to
the vast majority of caspase substrates, might be due to the ex-
posure of cryptic and potentially more immunogenic epitopes
that require swift uptake to avoid triggering of an autoim-
mune response (27). During granule-mediated cell death,
ROCK II cleavage by grB would maintain plasma membrane
bleb formation and autoantigen clustering, even in the face of
incomplete apoptotic signaling caused by deficient caspase ac-
tivation in virus-infected or malignant target cells.
 
MATERIALS AND METHODS
 
Cells and reagents.
 
LAK cells were prepared by overnight culture of hu-
man peripheral blood lymphocytes in the presence of 100 U/ml rIL-2 (Ce-
tus). z-VAD-fmk was purchased from Bachem and Y-27632 was provided
by A. Yoshimura (Yoshitomi Pharmaceuticals, Iruma, Japan). Plasmid con-
struction and purification of TAT-C3 protein were performed as described
previously (7). The following ROCK II antibodies were used: anti-ROK
 
 
 
(clone 21; BD Biosciences) and anti–ROCK II COOH terminus (C-20;
Santa Cruz Biotechnology, Inc.). The following ROCK II antibodies were
used: anti–ROCK II (H-85; Santa Cruz Biotechnology, Inc.) and anti–
Rock II COOH terminus (C-19; Santa Cruz Biotechnology, Inc.); anti-
cleaved (Asp175) caspase-3 (Cell Signaling); anti-AU1 (Babco); anti-MLC
(MY21; Sigma-Aldrich); and anti–MLC-PP, a gift from J.M. Straddon
(University College, London, UK). Purified grB was provided by C. Froe-
lish (Northwestern University, Evanston, IL), and KIAA0619 was provided
by T. Nagase (Kazusa DNA Research Institute, Chiba, Japan). 
 
Mice.
 
C57BL/6J mice were obtained from the Jackson Laboratory, and
B6.129S2-
 
Gzmb
 
tm1Ley
 
/J (
 
grB
 
 
 
/
 
 
 
) mice (29) were provided by A. Senik
(INSERM U542, Villejuif, France). Mice were bred and maintained in spe-
cific, pathogen-free, accredited facilities at the Centre National de la Re-
cherche Scientifique Unit 44. Male mice were used at 6 wk of age.
 
Western blots.
 
Cells were lysed in Triton X-100 buffer for ROCK de-
tection and in Laemmli buffer for caspases and MLC detection before elec-
trophoresis was performed on SDS-PAGE. Mobility shift of ADP-ribosy-
lated Rho was analyzed as previously described (7).
 
In vitro grB cleavage assay.
 
Subconfluent MCF-7 cells were lysed in
Triton X-100 buffer. ROCK immunoprecipitation was performed with
300 
 
 
 
g of protein per 4 
 
 
 
g anti–ROCK I (sc-H-85) or anti–ROCK II (sc-
C20) at 4
 
 
 
C for 6 h followed by protein G–Sepharose at 4
 
 
 
C for 1 h. In
vitro grB cleavage assay was performed as described previously (13).
 
In vivo granzyme B cleavage assay.
 
Subconfluent MCF-7 cultured in
6-well microplates were washed twice in serum-free medium, treated with
Chariot reagent (Active Motif; reference 16), and mixed with 2 
 
 
 
g of puri-
fied grB. Cells were lysed with Triton X-100 buffer before Western blot
analysis was performed.
 
ROCK II plasmid constructions.
 
cDNA coding for human ROCK II
(KIAA0619) was used as a template for PCR amplification with the follow-
ing primers: forward, 5
 
 
 
-ATGAGCCGGCCCCCGCCGACG-3
 
 
 
; and re-
verse, 5
 
 
 
-TTAGCTAGGTTTGTTTGGGGCAAGCTG-3
 
 
 
. Human ROCK
II cDNA was cloned in mammalian expression vector pcDNA
 
3
 
-AU1 at
BamHI and EcoRV sites. Uncleavable ROCK II was obtained by mutation
of asp
 
1131
 
 to alanine using the primer 5
 
 
 
-CCTTGCATATTGGTCTGGC-
CAGTTCCAGTATAGGCAG-3
 
 
 
, and ROCK II 
 
 
 
1131 was obtained by
asp
 
1131
 
 mutation in amber codon using the primer 5
 
 
 
-GCCTTGCATA-
TTGGTCTGGGCTAGCTCCAGTATAGGCAGTGGACCAGGG-3
 
 
 
,
with their respective complementary oligonucleotides by overlap extension,
using the QuikChange site-directed mutagenesis kit (Stratagene). Both mu-
tations were verified by sequencing.
 
GST-RhoA pull-down assay.
 
Escherichia coli
 
 expression of RhoA was
achieved by the use of pGEX-2T (Amersham Biosciences) encoding GST
fusion proteins. pGEX-transformed 
 
E. coli 
 
were grown to the mid-expo-
nential phase, induced for 5 h with 1 mM IPTG, and lysed in RIPA buffer
(50 mM Tris, pH 7.2, 1% Triton X-100, 0.5% DOC, 0.1% SDS, 150 mM
NaCl, 10 mM MgCl
 
2
 
, 170 
 
 
 
g ml
 
 
 
1
 
 PMSF, and 1 
 
 
 
g ml
 
 
 
1
 
 of protease in-
hibitors [aprotinin, leupeptin, and pepstatin]). The GST-RhoA was purified
from the bacterial lysate by incubating with glutathione-coupled Sepharose
beads (Amersham Biosciences), elution in a buffer containing 50 mM Tris,
pH 8, 150 mM NaCl, 5 mM MgCl
 
2
 
, 100 mM CaCl
 
2
 
, 10 mM DTT, and 10
mM reduced glutathione and dialysis against PBS/2 mM DTT.
50 
 
 
 
g GST-RhoA bound to glutathione-coupled Sepharose beads were
incubated with 0.1 mM GDP or 0.1 mM GTP
 
  
 
in PBS buffer supplemented
with 1 mM EDTA and 0.5 
 
 
 
M MgCl
 
2
 
 for 1 h at 4
 
 
 
C, and the bound nucle-
otide was stabilized with 10 mM MgCl
 
2
 
. MCF-7 cells, transiently transfected
with AU-1 tagged ROCK II constructs with Lipofectamine 2000 (Invitro-
gen), were lysed in Triton X-100 buffer and 2 mg of cell lysate was added to
the GST-RhoA-GDP or -GTP for 1 h at 4
 
 
 
C. Beads were washed in lysis
buffer, and the proteins associated with the GST-RhoA bound to the beads
were boiled and separated on SDS-PAGE. Immunoblotting was performed
with the anti-AU1 or anti–ROCK II (C20) antibodies.
 
ROCK II in vitro kinase assay.
 
293T cells, transfected with ROCK II
AU1-tagged constructs with Lipofectamine 2000, were used for in vitro ki-
nase assay as described previously (30). In brief, 24 h after transfection, cells
were lysed with Triton X-100 buffer and AU1-tagged ROCK II proteins
were immunoprecipitated with the anti-AU1 antibody. A kinase reaction
was performed with the immunoprecipitated proteins in the presence of
 
 
 
-[
 
32
 
P]ATP and myelin basic protein for 30 min. After boiling, the prepara-
tion was run on SDS-PAGE and transferred on polyvinylidene difluoride
membrane. For autoradiography, signals from 
 
32
 
P-labeled proteins were ac-
quired quantitatively with a phosphorimager (Molecular Dynamics), and for
Western blotting analysis of immunoprecipitated proteins, the membranes
were probed with the anti-AU1 antibody.
 
Detection of 
 
 
 
ROCK II–induced membrane blebbing. 293T cells
seeded on glass coverslips were cotransfected with ROCK II and pcDNA3-
EGFP plasmids, cultured for 20 h in the presence of z-VAD-fmk and fixed
in paraformaldehyde (4%) before performing analysis on a laser scanning
confocal microscope imaging system (Carl Zeiss MicroImaging, Inc.).JEM VOL. 201, February 7, 2005 471
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ROCK cleavage in YAC-1 cells exposed to activated murine NK
cells. Red cell-depleted splenocytes of C57BL/6J (WT) or B6.129S2-
Gzmbtm1Ley/J (gzmb / ) mice were cultured for 8 d in the presence of 500
U/ml rIL-2 (Cetus). Activated splenocytes were incubated with YAC-1
target cells at a ratio of 2:1 for the times indicated in the figures. Cell mix-
tures were lysed in Triton X-100 buffer before performing electrophoresis
on SDS-PAGE and blotting with anti-ROCK antibodies. Hsc-70 was used
as a loading control.
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